← Leaderboards
Jaroslaw Waldemar Zmijewski
University Of Alabama At Birmingham
$3,842,718
Attributed
$5,654,956
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $761.4K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,654,956 · 3
By mechanism
R01$5,654,956 · 3
Top collaborators
- Victor John Thannickal6 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Gang Liu$12,948,801
- Michael John Stec$233,235
- Upender Manne$11,389,346
- A Brent Carter$10,705,460
- Christopher Michael Taylor$3,588,060
Others in their field
Top investigators on “Novel Therapeutic Intervention”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$292,259,147
- Leonard Freedman · Leidos Biomedical Research, Inc.$247,367,648
- Daniel R Kuritzkes · Brigham And Women'S Hospital$246,024,897
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$193,480,690
Research focus
Novel Therapeutic InterventionAffectLung-Amp-Activated Protein Kinase5&AposMediatingLung InjuryEventFunctional DisorderSignal TransductionResolutionMacrophageCellsStk11 GeneResponseTissuesPhosphorylationMetabolicPreventPlayHomeostasisIdiopathic Pulmonary FibrosisFibrosisFunctional Outcomes
Grant awards (12)
AMPK in the Development and resolution of Lung Fibrosis$749,246
R01 · FY2025 · HL · contact PI
AMPK in the Development and resolution of Lung Fibrosis$761,371
R01 · FY2024 · HL · contact PI
AMPK in the Development and Resolution of Lung Fibrosis$528,465
R01 · FY2022 · HL · contact PI
AMPK in the Development and Resolution of Lung Fibrosis$528,465
R01 · FY2021 · HL · contact PI
AMPK in the Development and Resolution of Lung Fibrosis$528,465
R01 · FY2020 · HL · contact PI
AMPK in the Development and Resolution of Lung Fibrosis$528,465
R01 · FY2019 · HL · contact PI
AMPK activation and acute lung injury$360,756
R01 · FY2015 · HL · contact PI
AMPK activation and acute lung injury$358,925
R01 · FY2014 · HL · contact PI
AMPK activation and acute lung injury$348,670
R01 · FY2013 · HL · contact PI
AMPK activation and acute lung injury$366,250
R01 · FY2012 · HL · contact PI
HMGB1 and neutrophil efferocytosis.$297,939
R01 · FY2012 · GM · contact PI
HMGB1 and neutrophil efferocytosis.$297,939
R01 · FY2011 · GM · contact PI